Which has preferable valuation & earnings, BVC or RUA?

BATM Advanced Communications has higher revenue and earnings than RUA Life Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BATM Advanced Communications £123.20M 0.34 -£278.26K -£4.20 N/A RUA Life Sciences £4.11M 3.92 -£2.66M N/A N/A

Which has better earnings and valuation, IUG or RUA?

Intelligent Ultrasound Group has higher revenue and earnings than RUA Life Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Intelligent Ultrasound Group £6.57M 0.00 -£2.27M -£0.68 N/A RUA Life Sciences £4.11M 3.92 -£2.66M N/A N/A

Which has preferable valuation and earnings, NCYT or RUA?

RUA Life Sciences has lower revenue, but higher earnings than Novacyt. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Novacyt £20.03M 1.56 -£36.80M -£32.00 N/A RUA Life Sciences £4.11M 3.92 -£2.66M N/A N/A

Is NCYT or RUA more profitable?

RUA Life Sciences has a net margin of -3.26% compared to Novacyt's net margin of -103.08%. RUA Life Sciences' return on equity of -2.03% beat Novacyt's return on equity. Company Net Margins Return on Equity Return on Assets Novacyt -103.08% -96.44% -27.98% RUA Life Sciences -3.26% -2.03% -17.50%

Does the media favor NCYT or RUA?

In the previous week, Novacyt and Novacyt both had 1 articles in the media. Novacyt's average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Novacyt 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RUA Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, AKR or RUA?

Akers Biosciences has higher earnings, but lower revenue than RUA Life Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Akers Biosciences £2.32M 0.00 N/A -£129.60 N/A RUA Life Sciences £4.11M 3.92 -£2.66M N/A N/A

Which has stronger earnings & valuation, RUA or IHC?

RUA Life Sciences has higher earnings, but lower revenue than Inspiration Healthcare Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RUA Life Sciences £4.11M 3.92 -£2.66M N/A N/A Inspiration Healthcare Group £47.55M 0.36 -£12.20M -£1.16 N/A

Does the media favor RUA or IHC?

In the previous week, RUA Life Sciences and RUA Life Sciences both had 1 articles in the media. RUA Life Sciences' average media sentiment score of 0.00 equaled Inspiration Healthcare Group'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RUA Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inspiration Healthcare Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

RUA Life Sciences (RUA) Competitors

GBX 26 +1.50 (+6.12%)

As of 12:01 PM Eastern

Compare

RUA vs. BVC, IUG, NCYT, AKR, and IHC

Should you buy RUA Life Sciences stock or one of its competitors? RUA Life Sciences's main competitors and comparable companies include BATM Advanced Communications (BVC), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Akers Biosciences (AKR), and Inspiration Healthcare Group (IHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does RUA Life Sciences compare to BATM Advanced Communications?

BATM Advanced Communications (LON:BVC) and RUA Life Sciences (LON:RUA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

14.3% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 0.1% of RUA Life Sciences shares are owned by institutional investors. 31.0% of BATM Advanced Communications shares are owned by company insiders. Comparatively, 7.3% of RUA Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

BATM Advanced Communications has higher revenue and earnings than RUA Life Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BATM Advanced Communications	£123.20M	0.34	-£278.26K	-£4.20	N/A
RUA Life Sciences	£4.11M	3.92	-£2.66M	N/A	N/A

In the previous week, RUA Life Sciences had 1 more articles in the media than BATM Advanced Communications. MarketBeat recorded 1 mentions for RUA Life Sciences and 0 mentions for BATM Advanced Communications. BATM Advanced Communications' average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.

Company	Overall Sentiment
BATM Advanced Communications	Neutral
RUA Life Sciences	Neutral

BATM Advanced Communications has a beta of 0.754, meaning that its share price is 25% less volatile than the broader market. Comparatively, RUA Life Sciences has a beta of 0.948, meaning that its share price is 5% less volatile than the broader market.

RUA Life Sciences has a net margin of -3.26% compared to BATM Advanced Communications' net margin of -14.90%. RUA Life Sciences' return on equity of -2.03% beat BATM Advanced Communications' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BATM Advanced Communications	-14.90%	-22.13%	0.58%
RUA Life Sciences	-3.26%	-2.03%	-17.50%

Summary

RUA Life Sciences beats BATM Advanced Communications on 6 of the 11 factors compared between the two stocks.

How does RUA Life Sciences compare to Intelligent Ultrasound Group?

Intelligent Ultrasound Group (LON:IUG) and RUA Life Sciences (LON:RUA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

RUA Life Sciences has a net margin of -3.26% compared to Intelligent Ultrasound Group's net margin of -23.11%. RUA Life Sciences' return on equity of -2.03% beat Intelligent Ultrasound Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Ultrasound Group	-23.11%	-23.58%	-13.51%
RUA Life Sciences	-3.26%	-2.03%	-17.50%

Intelligent Ultrasound Group has higher revenue and earnings than RUA Life Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Ultrasound Group	£6.57M	0.00	-£2.27M	-£0.68	N/A
RUA Life Sciences	£4.11M	3.92	-£2.66M	N/A	N/A

75.5% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 0.1% of RUA Life Sciences shares are held by institutional investors. 12.8% of Intelligent Ultrasound Group shares are held by insiders. Comparatively, 7.3% of RUA Life Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, RUA Life Sciences had 1 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 1 mentions for RUA Life Sciences and 0 mentions for Intelligent Ultrasound Group. Intelligent Ultrasound Group's average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.

Company	Overall Sentiment
Intelligent Ultrasound Group	Neutral
RUA Life Sciences	Neutral

Intelligent Ultrasound Group has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market. Comparatively, RUA Life Sciences has a beta of 0.948, suggesting that its stock price is 5% less volatile than the broader market.

Summary

Intelligent Ultrasound Group and RUA Life Sciences tied by winning 5 of the 10 factors compared between the two stocks.

How does RUA Life Sciences compare to Novacyt?

Novacyt (LON:NCYT) and RUA Life Sciences (LON:RUA) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

In the previous week, Novacyt and Novacyt both had 1 articles in the media. Novacyt's average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Novacyt	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
RUA Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Novacyt has a beta of 1.105, indicating that its stock price is 11% more volatile than the broader market. Comparatively, RUA Life Sciences has a beta of 0.948, indicating that its stock price is 5% less volatile than the broader market.

RUA Life Sciences has a net margin of -3.26% compared to Novacyt's net margin of -103.08%. RUA Life Sciences' return on equity of -2.03% beat Novacyt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Novacyt	-103.08%	-96.44%	-27.98%
RUA Life Sciences	-3.26%	-2.03%	-17.50%

10.7% of Novacyt shares are owned by institutional investors. Comparatively, 0.1% of RUA Life Sciences shares are owned by institutional investors. 0.4% of Novacyt shares are owned by company insiders. Comparatively, 7.3% of RUA Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

RUA Life Sciences has lower revenue, but higher earnings than Novacyt.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Novacyt	£20.03M	1.56	-£36.80M	-£32.00	N/A
RUA Life Sciences	£4.11M	3.92	-£2.66M	N/A	N/A

Summary

RUA Life Sciences beats Novacyt on 6 of the 10 factors compared between the two stocks.

How does RUA Life Sciences compare to Akers Biosciences?

Akers Biosciences (LON:AKR) and RUA Life Sciences (LON:RUA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

Akers Biosciences has a net margin of 0.00% compared to RUA Life Sciences' net margin of -3.26%. Akers Biosciences' return on equity of 0.00% beat RUA Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Akers Biosciences	N/A	N/A	N/A
RUA Life Sciences	-3.26%	-2.03%	-17.50%

Akers Biosciences has higher earnings, but lower revenue than RUA Life Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akers Biosciences	£2.32M	0.00	N/A	-£129.60	N/A
RUA Life Sciences	£4.11M	3.92	-£2.66M	N/A	N/A

In the previous week, RUA Life Sciences had 1 more articles in the media than Akers Biosciences. MarketBeat recorded 1 mentions for RUA Life Sciences and 0 mentions for Akers Biosciences. Akers Biosciences' average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.

Company	Overall Sentiment
Akers Biosciences	Neutral
RUA Life Sciences	Neutral

0.1% of RUA Life Sciences shares are owned by institutional investors. 7.3% of RUA Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Akers Biosciences and RUA Life Sciences tied by winning 4 of the 8 factors compared between the two stocks.

How does RUA Life Sciences compare to Inspiration Healthcare Group?

RUA Life Sciences (LON:RUA) and Inspiration Healthcare Group (LON:IHC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

Inspiration Healthcare Group has a net margin of -2.19% compared to RUA Life Sciences' net margin of -3.26%. RUA Life Sciences' return on equity of -2.03% beat Inspiration Healthcare Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RUA Life Sciences	-3.26%	-2.03%	-17.50%
Inspiration Healthcare Group	-2.19%	-6.49%	-3.47%

0.1% of RUA Life Sciences shares are held by institutional investors. Comparatively, 7.4% of Inspiration Healthcare Group shares are held by institutional investors. 7.3% of RUA Life Sciences shares are held by insiders. Comparatively, 6.1% of Inspiration Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, RUA Life Sciences and RUA Life Sciences both had 1 articles in the media. RUA Life Sciences' average media sentiment score of 0.00 equaled Inspiration Healthcare Group'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RUA Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inspiration Healthcare Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

RUA Life Sciences has higher earnings, but lower revenue than Inspiration Healthcare Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RUA Life Sciences	£4.11M	3.92	-£2.66M	N/A	N/A
Inspiration Healthcare Group	£47.55M	0.36	-£12.20M	-£1.16	N/A

RUA Life Sciences has a beta of 0.948, meaning that its stock price is 5% less volatile than the broader market. Comparatively, Inspiration Healthcare Group has a beta of 0.857, meaning that its stock price is 14% less volatile than the broader market.

Summary

RUA Life Sciences beats Inspiration Healthcare Group on 6 of the 10 factors compared between the two stocks.

Get RUA Life Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RUA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RUA vs. The Competition

Export

Metric	RUA Life Sciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	LON Exchange
Market Cap	£16.14M	£5.73B	£6.99B	£2.88B
Dividend Yield	1.44%	1.78%	2.58%	6.09%
P/E Ratio	-2.61	25.00	268.64	368.35
Price / Sales	3.92	40.02	585.15	83,691.32
Price / Cash	2.40	33.55	28.89	27.89
Price / Book	1.22	6.19	11.31	7.32
Net Income	-£2.66M	£147.25M	£3.44B	£5.89B
7 Day Performance	8.33%	1.89%	2.27%	1.51%
1 Month Performance	15.25%	2.44%	-0.23%	2.50%
1 Year Performance	122.64%	9.91%	76.15%	73.97%

RUA Life Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RUA RUA Life Sciences	N/A	GBX 26 +6.1%	N/A	+104.1%	£16.14M	£4.11M	N/A	48
BVC BATM Advanced Communications	N/A	GBX 13 +0.8%	N/A	-17.9%	£44.21M	£123.20M	N/A	980	Gap Up
IUG Intelligent Ultrasound Group	N/A	N/A	N/A	N/A	£42.76M	£6.57M	N/A	65
NCYT Novacyt	N/A	GBX 36.20 -1.2%	N/A	+7.9%	£26.22M	£20.03M	N/A	120	News Coverage Positive News
AKR Akers Biosciences	N/A	N/A	N/A	N/A	£21.64M	£2.32M	N/A	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:RUA) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RUA Life Sciences (RUA) Competitors

RUA vs. BVC, IUG, NCYT, AKR, and IHC

How does RUA Life Sciences compare to BATM Advanced Communications?

Summary

How does RUA Life Sciences compare to Intelligent Ultrasound Group?

Summary

How does RUA Life Sciences compare to Novacyt?

Summary

How does RUA Life Sciences compare to Akers Biosciences?

Summary

How does RUA Life Sciences compare to Inspiration Healthcare Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RUA vs. The Competition

RUA Life Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RUA Life Sciences (RUA) Competitors

RUA vs. BVC, IUG, NCYT, AKR, and IHC

How does RUA Life Sciences compare to BATM Advanced Communications?

Do insiders and institutionals hold more shares of BVC or RUA?

Which has preferable valuation & earnings, BVC or RUA?

Does the media prefer BVC or RUA?

Which has more volatility and risk, BVC or RUA?

Is BVC or RUA more profitable?

Summary

How does RUA Life Sciences compare to Intelligent Ultrasound Group?

Is IUG or RUA more profitable?

Which has better earnings and valuation, IUG or RUA?

Do institutionals and insiders have more ownership in IUG or RUA?

Does the media refer more to IUG or RUA?

Which has more risk and volatility, IUG or RUA?

Summary

How does RUA Life Sciences compare to Novacyt?

Does the media favor NCYT or RUA?

Which has more risk and volatility, NCYT or RUA?

Is NCYT or RUA more profitable?

Do insiders and institutionals believe in NCYT or RUA?

Which has preferable valuation and earnings, NCYT or RUA?

Summary

How does RUA Life Sciences compare to Akers Biosciences?

Is AKR or RUA more profitable?

Which has stronger valuation and earnings, AKR or RUA?

Does the media favor AKR or RUA?

Do institutionals & insiders have more ownership in AKR or RUA?

Summary

How does RUA Life Sciences compare to Inspiration Healthcare Group?

Is RUA or IHC more profitable?

Do insiders and institutionals believe in RUA or IHC?

Does the media favor RUA or IHC?

Which has stronger earnings & valuation, RUA or IHC?

Which has more volatility & risk, RUA or IHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RUA vs. The Competition

RUA Life Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools